Answers are grounded in this paper and cite their sources.
This report from Uzbekistan describes the development of fluoroquinolone-resistant and extensively drug-resistant tuberculosis during second-line treatment for multidrug-resistant (MDR) tuberculosi...
No takes yet. Share an insight, caveat, or question.
Cox et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: